Literature DB >> 11478810

Tissue distribution and subcellular localization of a variant form of the human ST2 gene product, ST2V.

K Tago1, T Noda, M Hayakawa, H Iwahana, K Yanagisawa, T Yashiro, S Tominaga .   

Abstract

The human ST2 gene has been known to encode three splice variants; namely, a soluble secreted form of ST2, a transmembrane form of ST2L, and ST2V of undetermined localization. Therefore, analysis of tissue distribution and subcellular localization of ST2V is important to elucidate functional relationships among the three splice variants of the human ST2 gene. RT-PCR procedure revealed that ST2V is predominantly expressed in the stomach, small intestine, and colon. Transfection of ST2V cDNA into COS7 cells in the presence of [(35)S] methionine and cysteine produced radiolabeled 40 kDa protein, which is recognized by specific monoclonal antibody against human ST2. Subcellular fractionation analysis showed that ST2V protein was distributed in the insoluble fraction of the cell lysate. Finally, ST2V protein was detected on the plasma membrane of COS7 cells, which had been transfected with ST2V cDNA, by confocal laser microscopic analysis. These findings taken together, indicate that ST2V protein localizes on the plasma membrane, suggesting its possible role in modification of the ST2L-signaling pathways. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11478810     DOI: 10.1006/bbrc.2001.5306

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  43 in total

Review 1.  Interleukin-33 biology with potential insights into human diseases.

Authors:  Gaby Palmer; Cem Gabay
Journal:  Nat Rev Rheumatol       Date:  2011-04-26       Impact factor: 20.543

Review 2.  IL-33 family members and asthma - bridging innate and adaptive immune responses.

Authors:  Clare M Lloyd
Journal:  Curr Opin Immunol       Date:  2010-11-09       Impact factor: 7.486

3.  Murine mast cells secrete and respond to interleukin-33.

Authors:  Hui-Ying Tung; Beverly Plunkett; Shau-Ku Huang; Yufeng Zhou
Journal:  J Interferon Cytokine Res       Date:  2013-09-12       Impact factor: 2.607

Review 4.  Role of the IL-33/ST2 receptor axis in ovarian cancer progression.

Authors:  Ning Liu; Jintong Chen; Yinghua Zhao; Mingyue Zhang; Li Piao; Siqing Wang; Ying Yue
Journal:  Oncol Lett       Date:  2021-04-29       Impact factor: 2.967

5.  ST2 gene expression is proliferation-dependent and its ligand, IL-33, induces inflammatory reaction in endothelial cells.

Authors:  Shinsuke Aoki; Morisada Hayakawa; Hiromi Ozaki; Naoki Takezako; Hiroto Obata; Nobuhiro Ibaraki; Tadahiko Tsuru; Shin-Ichi Tominaga; Ken Yanagisawa
Journal:  Mol Cell Biochem       Date:  2009-09-12       Impact factor: 3.396

Review 6.  Biomarkers for risk prediction in acute decompensated heart failure.

Authors:  A Rogier van der Velde; Wouter C Meijers; Rudolf A de Boer
Journal:  Curr Heart Fail Rep       Date:  2014-09

Review 7.  Novel Biomarkers in Heart Failure Beyond Natriuretic Peptides - The Case for Soluble ST2.

Authors:  Antonio J Vallejo-Vaz
Journal:  Eur Cardiol       Date:  2015-07

Review 8.  Disease-associated functions of IL-33: the new kid in the IL-1 family.

Authors:  Foo Y Liew; Nick I Pitman; Iain B McInnes
Journal:  Nat Rev Immunol       Date:  2010-01-18       Impact factor: 53.106

Review 9.  The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

10.  The GOLD domain-containing protein TMED1 is involved in interleukin-33 signaling.

Authors:  Dympna J Connolly; Luke A J O'Neill; Anne F McGettrick
Journal:  J Biol Chem       Date:  2013-01-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.